Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2056-5968
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2 ; volume:8 ; number:1 ; day:19 ; month:7 ; year:2022 ; pages:1-4 ; date:12.2022
Cell discovery ; 8, Heft 1 (19.7.2022), 1-4, 12.2022

Creator
Fang, Zhenhao
Peng, Lei
Lucas, Carolina
Lin, Qianqian
Zhou, Liqun
Yang, Luojia
Feng, Yanzhi
Ren, Ping
Renauer, Paul A.
Monteiro, Valter S.
Hahn, Anne M.
Park, Jonathan J.
Zhou, Xiaoyu
Grubaugh, Nathan D.
Wilen, Craig B.
Chen, Sidi
Contributor
SpringerLink (Online service)

DOI
10.1038/s41421-022-00435-w
URN
urn:nbn:de:101:1-2022100120394723918232
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:25 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Fang, Zhenhao
  • Peng, Lei
  • Lucas, Carolina
  • Lin, Qianqian
  • Zhou, Liqun
  • Yang, Luojia
  • Feng, Yanzhi
  • Ren, Ping
  • Renauer, Paul A.
  • Monteiro, Valter S.
  • Hahn, Anne M.
  • Park, Jonathan J.
  • Zhou, Xiaoyu
  • Grubaugh, Nathan D.
  • Wilen, Craig B.
  • Chen, Sidi
  • SpringerLink (Online service)

Other Objects (12)

Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants

Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants

mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant

mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant

Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland

Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland

Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2

Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2

Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history

Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern

Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern

Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges

Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges

Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients

Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients

Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2

Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2

SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants

SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants

Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections

Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections

Related objects